+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

From
From
From
From
Global Neuromuscular Disease Therapeutics Market 2021-2025 - Product Thumbnail Image

Global Neuromuscular Disease Therapeutics Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
From
Duchenne Muscular Dystrophy Global Market Report 2023 - Product Thumbnail Image

Duchenne Muscular Dystrophy Global Market Report 2023

  • Report
  • July 2023
  • 275 Pages
  • Global
From
Limb Girdle Muscular Dystrophy - Pipeline Insight, 2022 - Product Thumbnail Image

Limb Girdle Muscular Dystrophy - Pipeline Insight, 2022

  • Clinical Trials
  • August 2022
  • 80 Pages
  • Global
From
Duchenne Muscular Dystrophy - Pipeline Insight, 2022 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Insight, 2022

  • Clinical Trials
  • July 2022
  • 200 Pages
  • Global
From
From
Loading Indicator